PIPF 031: A Treatment Protocol to Allow Patients in the US with Idiopathic Pulmonary Fibrosis Access to Pirfenidone

Trial ID or NCT#

NCT02141087

Status

not recruiting iconNOT RECRUITING

Purpose

This is an open label multi-center program to allow patients in the US with IPF access to treatment with pirfenidone.